Glomerular barrier function following conversion from cyclosporine to azathioprine in renal transplant recipients. 1994

R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
Department of Internal Medicine I, University Hospital Rotterdam-Dijkzigt, The Netherlands.

The renal side effects are the major limitation of the use of cyclosporine in clinical transplantation. We studied the reversibility of changes in renal hemodynamics and glomerular barrier function in 17 patients with moderately impaired renal function at least 1 year after kidney transplantation. All patients were studied both during cyclosporine treatment and 3 months after conversion to azathioprine. During azathioprine treatment both glomerular filtration rate and effective renal plasma flow increased significantly (from 44.3 +/- 4.2 mL/min to 63.5 +/- 5.4 mL/min and from 192 +/- 12.8 mL/min to 260 +/- 14.6 mL/min, respectively). Despite the marked changes in renal hemodynamics, no significant changes were observed in the fractional clearances of uncharged dextrans. When calculating the characteristics of the filtration barrier, we observed a trend toward an increase in the ultrafiltration coefficient (Kt). This trend was abolished when an increase in net filtration pressure (delta P) was assumed to result from reduced prerenal vasoconstriction. We conclude that despite marked improvement of renal perfusion and glomerular filtration, conversion from cyclosporine to azathioprine did not significantly alter the permeability characteristics of the glomerular filtration barrier in renal transplant recipients with moderately reduced renal function. Improvement in renal function following conversion could result from an increase in either Kf or delta P. Since renal plasma flow was increased significantly, the observed improvement in glomerular filtration rate is likely to be, at least in part, due to an increase in glomerular capillary plasma flow.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
November 1998, Transplantation proceedings,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
January 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
January 1988, The Journal of heart transplantation,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
December 1984, Transplantation,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
August 1985, Transplantation proceedings,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
October 2006, Kidney international,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
January 1999, Transplantation proceedings,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
June 1999, Arteriosclerosis, thrombosis, and vascular biology,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
January 1989, International journal of immunopharmacology,
R Zietse, and M L van Ierland-van Leeuwen, and F H Derkx, and J N Ijzermans, and M A Schalekamp, and W Weimar
December 2000, Clinical transplantation,
Copied contents to your clipboard!